Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Lewey

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Circulation|January 15, 2025
Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart AssociationRina Mauricio, Garima Sharma, Jennifer Lewey, et al.
Medical Care|July 26, 2018
Comparison of Pharmacy Claims and Electronic Pill Bottles for Measurement of Medication Adherence Among Myocardial Infarction PatientsShivan J Mehta, David A Asch, Andrea B Troxel, et al.
Circulation|February 12, 2024
Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart AssociationJennifer Lewey, Theresa M Beckie, Haywood L Brown, et al.
Plos One|April 3, 2019
Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trialJulie C Lauffenburger, Roya Ghazinouri, Saira Jan, et al.
Journal of the American Heart Association|December 10, 2025
Association Between Uterine Fibroids and Risk of Atherosclerotic Cardiovascular DiseaseJulia D DiTosto, Jennifer Lewey, Jarcy Zee, et al.
JACC. Advances|June 18, 2026
Cardiometabolic Health in Pregnancy: Prevention, Management, and Long-Term ImplicationsColleen M Harrington, Amy Sarma, Amanda Jowell, et al.
Contemporary Clinical Trials|June 3, 2017
Rationale and design of the ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic trialJulie C Lauffenburger, Jennifer Lewey, Saira Jan, et al.
Fertility and Sterility|May 19, 2026
Emulating a Target Trial of Surgical Removal of Uterine Fibroids on Atherosclerotic Cardiovascular DiseaseJulia D DiTosto, Jennifer Lewey, Jarcy Zee, et al.
JAMA Cardiology|July 26, 2023
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic ReviewKriyana P Reddy, Michela Faggioni, Lauren A Eberly, et al.
Circulation|February 13, 2023
Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart AssociationSadiya S Khan, LaPrincess C Brewer, Mary M Canobbio, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Circulation|January 15, 2025
Assessing and Addressing Cardiovascular and Obstetric Risks in Patients Undergoing Assisted Reproductive Technology: A Scientific Statement From the American Heart AssociationRina Mauricio, Garima Sharma, Jennifer Lewey, et al.
Medical Care|July 26, 2018
Comparison of Pharmacy Claims and Electronic Pill Bottles for Measurement of Medication Adherence Among Myocardial Infarction PatientsShivan J Mehta, David A Asch, Andrea B Troxel, et al.
Circulation|February 12, 2024
Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart AssociationJennifer Lewey, Theresa M Beckie, Haywood L Brown, et al.
Plos One|April 3, 2019
Impact of a novel pharmacist-delivered behavioral intervention for patients with poorly-controlled diabetes: The ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic randomized trialJulie C Lauffenburger, Roya Ghazinouri, Saira Jan, et al.
Journal of the American Heart Association|December 10, 2025
Association Between Uterine Fibroids and Risk of Atherosclerotic Cardiovascular DiseaseJulia D DiTosto, Jennifer Lewey, Jarcy Zee, et al.
JACC. Advances|June 18, 2026
Cardiometabolic Health in Pregnancy: Prevention, Management, and Long-Term ImplicationsColleen M Harrington, Amy Sarma, Amanda Jowell, et al.
Contemporary Clinical Trials|June 3, 2017
Rationale and design of the ENhancing outcomes through Goal Assessment and Generating Engagement in Diabetes Mellitus (ENGAGE-DM) pragmatic trialJulie C Lauffenburger, Jennifer Lewey, Saira Jan, et al.
Fertility and Sterility|May 19, 2026
Emulating a Target Trial of Surgical Removal of Uterine Fibroids on Atherosclerotic Cardiovascular DiseaseJulia D DiTosto, Jennifer Lewey, Jarcy Zee, et al.
JAMA Cardiology|July 26, 2023
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic ReviewKriyana P Reddy, Michela Faggioni, Lauren A Eberly, et al.
Circulation|February 13, 2023
Optimizing Prepregnancy Cardiovascular Health to Improve Outcomes in Pregnant and Postpartum Individuals and Offspring: A Scientific Statement From the American Heart AssociationSadiya S Khan, LaPrincess C Brewer, Mary M Canobbio, et al.
Pageof 9